Flu, Clinical Trials | search
Click here to view Flu, Clinical Trials news from 60+ newspapers.
Bookmark or Share- Safety and immunogenicity of mRNA-based seasonal influenza vaccines ...One phase 1/2 clinical trial was identified, describing the safety and immunogenicity of a quadrivalent mRNA-based seasonal influenza vaccine containing mRNAs encoding haemagglutinins of four influenza strains (A/H1N1, A/H3N2, B/Victoria, and B/Yamagata) recommended by WHO.
- Trial of potential universal flu vaccine opens at NIH Clinical CenterA Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The placebo-controlled trial will test the safety of a candidate vaccine, BPL-1357, and its ability to prompt immune responses.
- NIH clinical trial of universal flu vaccine candidate beginsThe new clinical trial is expected to enroll 24 healthy volunteers, aged 18-50 years, who will receive two intramuscular injections of the FluMos-v2 vaccine candidate. These injections will be given 16 weeks apart.
- NIH Clinical Trial of Universal Flu Vaccine Candidate BeginsThe new clinical trial is expected to enroll 24 healthy volunteers, aged 18-50 years, who will receive two intramuscular injections of the FluMos-v2 vaccine candidate. These injections will be given 16 weeks apart.
- Clinical Trial of mRNA Universal Influenza Vaccine Candidate BeginsThis Phase 1 trial will test the experimental vaccine, known as H1ssF-3928 mRNA-LNP, for safety and its ability to induce an immune response. The trial will enroll up to 50 healthy volunteers aged 18 through 49.
More
